In vitro phenotypic susceptibility of HIV-1 non-group M to CCR5 inhibitor (maraviroc): TROPI-CO study

ABSTRACT The susceptibility of genetically divergent HIV-1 strains (HIV-1 non-M) from groups O, N, and P to the CCR5 co-receptor antagonist, maraviroc (MVC), was investigated among a large panel of 45 clinical strains, representative of the viral genetic diversity. The results were compared to the r...

Descripció completa

Dades bibliogràfiques

Autors principals:	Ségolène Gracias, Ikrame El Yaalaoui, Benoît Visseaux, Charlotte Charpentier, Diane Descamps, Charlène Martin, Fanny Lermechain, Jean-Christophe Plantier, Elodie Alessandri-Gradt
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Microbiology 2024-07-01
Col·lecció:	Microbiology Spectrum
Matèries:	human immunodeficiency virus genetic diversity phenotypic susceptibility maraviroc
Accés en línia:	https://journals.asm.org/doi/10.1128/spectrum.03895-23
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!